718 Treatment results in high risk hepatoblastoma: analysis of prognostic factors. Results from SIOPEL 2 and 3 trials

J.Zsiros; R.Maibach; G.Perilongo; P.Brock; P.Czauderna; L.Brugieres; G.MacKinlay; A.Zimmermann; D.Roebuck; J.Plaschkes

首页> 外文期刊>European Journal of Cancer Supplements >718 Treatment results in high risk hepatoblastoma: analysis of prognostic factors. Results from SIOPEL 2 and 3 trials

【24h】

718 Treatment results in high risk hepatoblastoma: analysis of prognostic factors. Results from SIOPEL 2 and 3 trials

机译：718治疗可导致高危肝母细胞瘤：预后因素分析。 SIOPEL 2和3试验的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共1页
作者
J.Zsiros; R.Maibach; G.Perilongo; P.Brock; P.Czauderna; L.Brugieres; G.MacKinlay; A.Zimmermann; D.Roebuck; J.Plaschkes;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Two Year Results of a Randomised Phase III Trial for Standard Risk Hepatoblastoma (SR-HB) SIOPEL 6; Cisplatin and Sodium Thiosulfate (STS) Vs Cisplatin Alone [J] . Brock P., Childs M., Rajput K., Pediatric blood & cancer . 2016,第Suppla3期

机译：标准风险肝母细胞瘤（SR-HB）SIOPEL 6的III期随机试验的两年结果;顺铂和硫代硫酸钠（STS）与单独的顺铂
2. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials [J] . Daniel C Aronson MD PhD, Piotr Czauderna, Rudolf Maibach, Journal of Indian association of pediatric surgeons . 2014,第4期

机译：肝母细胞瘤的治疗：根据SIOPEL试验的进展和现状
3. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - A phase II trial of the childhood liver tumour strategy group (SIOPEL) [J] . ZsírosJ., BrugièresL., BrockP., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2012,第18期

机译：伊立替康单药治疗儿童难治性或复发性肝母细胞瘤的有效性-儿童肝肿瘤策略组（SIOPEL）的II期临床试验
4. The changing but continued role of surgery in the management of liver tumours Hepatoblastoma (HB) and Hepatocellular Carcinoma (HCC) in children and adolescents in the -light of new results from the SIOPEL Studies- past experience and future perspectives [C] . . 2006

机译：根据SIOPEL研究的新结果-过去的经验和未来的观点，外科手术在儿童和青少年肝肿瘤肝母细胞瘤（HB）和肝细胞癌（HCC）处理中的作用不断变化，但仍在继续
5. Symptom status and risk factors of adolescents in residential treatment: Developing norms for the Youth Outcome Questionnaire (Y-OQ) and determining the utility of the Y-OQ and the Y-OQ Prognostic Assessment (Y-OQ PA) in predicting treatment setting [D] . Gillman, Kreg D. 1998

机译：青少年在住院治疗中的症状状态和危险因素：制定青年结局问卷（Y-OQ）规范，确定Y-OQ和Y-OQ预后评估（Y-OQ PA）在预测治疗环境中的效用
6. Screening asymptomatic patients with diabetes for unknown coronary artery disease: Does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D Trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?) [O] . Fabrizio Turrini, Roberto Messora, Paolo Giovanardi, 2009

机译：对无症状糖尿病患者进行未知冠状动脉疾病筛查：这会降低风险吗？一项开放标签的随机试验将基于针对血运重建的运动测试策略与基于传统危险因素的药理/行为治疗的管理进行了比较。 DADDY-D试验（在糖尿病患者中应该对冠状动脉粥样硬化进行早期诊断和治疗吗？）
7. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials [O] . Daniel C Aronson, Piotr Czauderna, Rudolf Maibach, 2014

机译：肝母细胞瘤的治疗：根据sIOpEL试验的进展和现状
8. Determination of Medical Practice Regarding Coronary Heart Disease Risk Factors. Baseline Measurements of Practice Before Release of Results of the Coronary Primary Prevention Trial [R] . Mackintosh, D. , Jajich, C. , Antetomaso, J. , 1984

机译：关于冠心病危险因素的医学实践的确定。在冠状动脉一级预防试验结果公布之前的实践基线测量

718 Treatment results in high risk hepatoblastoma: analysis of prognostic factors. Results from SIOPEL 2 and 3 trials

著录项

相似文献

相关主题

期刊订阅